|
Contents
|
|
|
|
Atypical
teratoid / rhabdoid t.
|
|
|
|
|
Gidwani P, Levy A, Goodrich J, Weidenheim K,
Kolb EA.
Successful outcome with tandem myeloablative chemotherapy and autologous
peripheral blood stem cell transplants in a patient with atypical teratoid/rhabdoid
tumor of the central nervous system
J Neurooncol.
2008 Jun;88(2):211-5.
Epub 2008 Mar 04
.JPG)
Abstract
|
|
|
Nicolaides T, Tihan T, Horn B, Biegel J, Prados
M, Banerjee A
High-dose
chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid
tumor of the central nervous system
J
Neurooncol. 2010 May;98(1):117-23. Epub 2009 Nov 22
Abstract | .png)
Full Text | .png)
Reprint | .gif)
Related articles
|
|
|
Brain
Tumors
|
|
|
|
|
Drappatz
J, Schiff D, Kesari S, Norden AD, Wen PY.
Medical management of brain tumor patients.
Neurol Clin.
2007 Nov;25(4):1035-71.
Abstract
|
|
|
Weller M
Chemotherapy for brain tumors in adult patients
Nervenarzt. 2008 Feb 6; 79(2):231-41
Abstract
|
|
|
Choroid
Plexus Tumors
|
|
|
|
|
Wrede B, Liu P, Wolff JE
Chemotherapy improves the survival of patients with choroid plexus
carcinoma: a meta-analysis of individual cases with choroid plexus tumors
J Neurooncol.
2007 Dec;85(3):345-51.
Epub 2007 Jun 19
Abstract |
Reprint
|
|
|
Gliomatosis
Cerebri
|
|
|
|
|
Kong DS, Kim ST, Lee
JI, Suh YL, Lim DH, Kim WS, Kwon KH, Park K, Kim JH, Nam DH
Impact
of adjuvant chemotherapy for gliomatosis cerebri
BMC Cancer 2010, 10:424
(13 August 2010)
Abstract |
Reprint
|
|
|
Hemangiopericytoma
|
|
|
|
|
Chamberlain MC, Glantz MJ
Sequential salvage chemotherapy for recurrent intracranial
hemangiopericytoma
Neurosurgery. 2008 Oct;63(4):720-6; author reply 726-7
Abstract
|
|
|
Medulloblastoma
|
|
|
|
|
Gajjar A
High-dose chemotherapy for recurrent medulloblastoma: time for a
reappraisal
Cancer. 2008 Apr
15;112(8):1643-5. Epub 2008 Feb 27.
Abstract |
Reprint
| Related articles
|
|
|
Gottardo NG, Gajjar A.
Chemotherapy
for malignant brain tumors of childhood.
J
Child Neurol. 2008 Oct;23(10):1149-59.
Abstract |
Reprint |
Related articles
|
|
|
Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero
CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan
P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza
C, Polastri D, Ravagnani F, Fossati-Bellani F
No
Salvage Using High-Dose Chemotherapy Plus/Minus Reirradiation for Relapsing
Previously Irradiated Medulloblastoma
Int
J Radiat Oncol Biol Phys. 2008 Nov 17. [Epub ahead of print]
Abstract
|
|
|
Panosyan
EH, Ikeda AK, Chang VY, Laks DR, Reeb CL, Bowles LV, Lasky JL 3rd, Moore TB.
High-dose chemotherapy with
autologous hematopoietic stem-cell rescue for pediatric brain tumor
patients:
a single institution experience from UCLA.
J Transplant. 2011;2011:740673.
Epub 2011 Apr 14.
Abstract |
Reprint |
Related articles
|
|
|
Varan
A.
Risk-adapted chemotherapy in
childhood medulloblastoma.
Expert Rev Anticancer Ther.
2011 May;11(5):771-80.
Abstract |
Related articles
|
|
|
Metastatic
Tumors
|
|
|
|
|
Cavaliere
R, Schiff D.
Chemotherapy and cerebral metastases: misperception or reality?
Neurosurg Focus.
2007 Mar 15;22(3):E6.
PMID:
17608359 [PubMed - in process]
|
|
|
Mehta
MP, Paleologos NA, Mikkelsen T, Robinson PD, Ammirati M, Andrews DW, Asher
AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS,
McDermott M, Olson JJ, Patchell RA, Ryken TC, Kalkanis SN
The role of chemotherapy in the management of newly diagnosed brain
metastases: a systematic review and evidence-based clinical practice
guideline
J Neurooncol.
2009 Dec 4. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
|
|
Oligodendroglial
Tumors
|
|
|
|
JG Cairncross, K Ueki, MC Zlatescu, DK
Lisle, DM Finkelstein, RR Hammond, JS Silver, PC Stark, DR Macdonald, Y Ino,
DA Ramsay and DN Louis
Specific genetic predictors
of chemotherapeutic response and survival in patients with anaplastic
oligodendrogliomas
Journal Of The National Cancer Institute, Vol 90, 1473-1479; 7 October 1998.
(PDF Full Text)
|
|
|
Sunyach MP, Jouvet A, Perol D, Jouanneau E,
Guyotat J, Gignoux L, Carrie C, Frappaz D
Role of exclusive chemotherapy as first line treatment in
oligodendroglioma
J Neurooncol.
2007 Dec;85(3):319-28.
Epub 2007 Jun 14
Abstract |
Reprint
|
|
|
Rhabdomyosarcoma
|
|
|
|
M. Stevens, A. Rey, N. Bouvet,
C. Ellershaw, J. Sanchez de Toledo, O. Oberlin
SIOP MMT 95: Intensified (6 drug) versus standard
(IVA) chemotherapy for high risk non metastatic rhabdomyosarcoma (RMS)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8515
|
|
|
Tumors
|
|
|
|
|
Garattini S, Bertele' V.
Efficacy, safety, and cost of new
anticancer drugs.
BMJ 2002;325:269-271 (3 August 2002).
Abstract |
Full Text |
Reprint
|
|
